or Try an Advanced Search...

    Diabetes Care Stocks List

    Symbol Grade Name % Change
    NVO A Novo Nordisk A/S 1.15
    TNDM B Tandem Diabetes Care, Inc. -3.33
    PRGO F Perrigo Company -4.13
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene

    Related ETFs - A few ETFs which own one or more of the above listed Diabetes Care stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 22.33
    PPH A Market Vectors Pharmaceutical ETF 10.33
    IGTR B Innovator Gradient Tactical Rotation Strategy ETF 8.56
    PJIO A PGIM Jennison International Opportunities ETF 7.63
    GK B AdvisorShares Gerber Kawasaki ETF 6.63
    View all Diabetes Care ETFs...
    Compare ETFs
    Compare PJIO to GK Compare PPH to GK Compare PPH to PJIO

        Diabetes Care Stocks Recent News

        Date Stock Title
        May 22 NVO Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
        May 22 NVO Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.
        May 22 TNDM Citi upgrades Edwards, Tandem; cuts Nevro, Establishment Labs
        May 22 NVO Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
        May 22 NVO Novo Nordisk Once-Weekly Insulin Icodec Poses Hypoglycemia Risk, FDA Says
        May 22 NVO Wall Street Lunch: Australia Bans Copycat Weight Loss Drugs
        May 22 NVO Top Research Reports for Novo Nordisk, QUALCOMM & Caterpillar
        May 22 NVO FDA reviewers voice concerns over hypoglycemia with Novo Nordisk weekly insulin
        May 22 NVO Novo Nordisk office building fire brought under control (update)
        May 22 NVO Play These New ETFs to Tap Lucrative Weight Loss Drug Market
        May 22 NVO Australia to ban copycat versions of weight loss drugs like Ozempic
        May 22 NVO This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
        May 21 NVO Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
        May 21 NVO Study finds 30% of Wegovy, Saxenda users quit within 4 weeks
        May 21 NVO Novo Nordisk unsure when it will meet obesity drug demand: report
        May 21 NVO Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
        May 21 NVO Eli Lilly's diabetes drug tirzepatide gets approval in China
        May 20 NVO Hims & Hers Health to Offer GLP-1 Weight Loss Injections; Stock Soars
        May 20 NVO Hims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.
        May 20 NVO Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene
        Diabetes Care

        Diabetes Care is a monthly peer-reviewed medical journal published since 1978 by the American Diabetes Association. The journal covers research in the following five categories: 1) clinical care/education/nutrition/psychosocial research, 2) epidemiology/health services research, 3) emerging treatments and technologies, 4) pathophysiology/complications, and 5) cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries.According to the Journal Citation Reports, the journal has a 2017 impact factor of 13.397 ranking it fifth out of 138 journals in the category "Endocrinology & Metabolism."

        More about Diabetes Care
        Browse All Tags